Publicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (16)

2023

  1. Epidemiology of human papillomavirus-associated anogenital cancers in Granada: a three-decade population-based study

    Frontiers in Public Health, Vol. 11

  2. Health-related quality of life in patients newly diagnosed with prostate cancer: CAPLIFE study

    Quality of Life Research, Vol. 32, Núm. 4, pp. 977-988

2022

  1. Dietary Patterns and Prostate Cancer: CAPLIFE Study

    Cancers, Vol. 14, Núm. 14

  2. Salivary Melatonin Rhythm and Prostate Cancer: CAPLIFE Study

    Journal of Urology, Vol. 207, Núm. 3, pp. 565-572

2020

  1. Compliance with the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and Prostate Cancer

    Nutrients, Vol. 12, Núm. 3

  2. Compliance with the 2018 world cancer research fund/American institute for cancer research cancer prevention recommendations and prostate cancer

    Nutrients, Vol. 12, Núm. 3

  3. Night shift work, chronotype, sleep duration, and prostate cancer risk: Caplife study

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 17, pp. 1-17

  4. The effect of an online exercise programme on bone health in paediatric cancer survivors (iBoneFIT): Study protocol of a multi-centre randomized controlled trial

    BMC Public Health, Vol. 20, Núm. 1

2019

  1. Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Costs associated with influenza-related hospitalization in the elderly

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 2, pp. 412-416

2016

  1. Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases

    Oncology Letters, Vol. 12, Núm. 5, pp. 3127-3134

2015

  1. Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792

2014

  1. Disease-free survival related factors in breast cancer

    Medicina Clinica, Vol. 143, Núm. 7, pp. 293-299

2013

  1. Prevalencia de obesidad infantil y juvenil en España en 2012

    Revista Espanola de Cardiologia, Vol. 66, Núm. 5, pp. 371-376

  2. Risk of second primary cancer among women with breast cancer: A population-based study in Granada (Spain)

    Gynecologic Oncology, Vol. 130, Núm. 2, pp. 340-345

2009

  1. Plasmacytoid lymphoma treated with rituximab as fi rst-line monotherapy

    Clinical and Translational Oncology